← Leaderboards
Alessandro D Santin
University Of Arkansas Med Scis Ltl Rock
$5,270,077
Attributed
$5,270,077
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $693.8K · FY2008–18$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$5,270,077 · 4
By mechanism
R01$3,059,441 · 2
U01$1,741,000 · 1
R21$469,636 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsGene ExpressionIn VivoCancer PatientBaseGenesClinically RelevantIn VitroMalignant NeoplasmsSerousTumorDiagnosisPreventDesignCell LineChemotherapyEffective TherapyXenograft ProcedureOverexpressionResearch StudyBiologicalDrug KineticsBinding (Molecular Function)Epithelial
Grant awards (16)
Integrated genomic analysis of racial disparities in endometrial cancer$347,588
U01 · FY2018 · CA · contact PI
Integrated genomic analysis of racial disparities in endometrial cancer$348,353
U01 · FY2017 · CA · contact PI
Integrated genomic analysis of racial disparities in endometrial cancer$348,353
U01 · FY2016 · CA · contact PI
Integrated genomic analysis of racial disparities in endometrial cancer$348,353
U01 · FY2015 · CA · contact PI
CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res$345,488
R01 · FY2015 · CA · contact PI
Integrated genomic analysis of racial disparities in endometrial cancer$348,353
U01 · FY2014 · CA · contact PI
CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res$335,123
R01 · FY2014 · CA · contact PI
CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res$324,596
R01 · FY2013 · CA · contact PI
CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res$344,277
R01 · FY2012 · CA · contact PI
CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res$343,413
R01 · FY2011 · CA · contact PI
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE$329,744
R01 · FY2011 · CA · contact PI
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE$344,171
R01 · FY2010 · CA · contact PI
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE$346,357
R01 · FY2009 · CA · contact PI
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE$346,272
R01 · FY2008 · CA · contact PI
Dendritic Cell Immunotherapy for Cervical Cancer$234,818
R21 · FY2004 · CA
Dendritic Cell Immunotherapy for Cervical Cancer$234,818
R21 · FY2003 · CA